Last update 25 Apr 2025

Fenoldopam Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fenoldopam, Fenoldopam mesylate (USP), (±)-SKF-82526
+ [8]
Action
agonists
Mechanism
ADRA2 agonists(Adrenergic receptors alpha-2 agonists), D1 receptor agonists(Dopamine D1 receptor agonists)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (23 Sep 1997),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H20ClNO6S
InChIKeyCVKUMNRCIJMVAR-UHFFFAOYSA-N
CAS Registry67227-57-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
United States
23 Sep 1997
Hypertension, Malignant
United States
23 Sep 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Kidney InjuryPhase 2-01 May 2002
Heart DiseasesPhase 2-01 May 2002
Kidney Failure, ChronicPhase 2-01 May 2002
Essential HypertensionPhase 1
China
18 Aug 2017
Secondary hypertensionPhase 1
China
05 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
3,339
xbitelanzj(bxnbxxmsdn) = It is uncertain whether adverse events (hypotension, myocardial infarction, drug intolerance, cardiac arrhythmias) differed between the treatment groups as the certainty of the evidence was very low. wbpqfoskiu (nwssmquyzy )
Positive
28 Nov 2024
Phase 2/3
1
0.9%NS
(Control)
yddbrpuntw(sqjihuauia) = ojonppynwn clwqcyltbv (dfdcqnjyqb, ycivkoctwr - ovsrxjbedf)
-
16 Sep 2022
(Fenoldopam)
yddbrpuntw(sqjihuauia) = vgqwyiiksh clwqcyltbv (dfdcqnjyqb, woktqrufdb - yzcwjdqlwk)
Not Applicable
90
Placebo
(Placebo)
amkpqfnfkn(xdkkeorswu) = khlnnruibd fcvctlmqbl (mmowibldul, 28)
-
31 Oct 2016
(Fenoldopam)
amkpqfnfkn(xdkkeorswu) = feuonkcqjr fcvctlmqbl (mmowibldul, 38)
Phase 3
-
667
kyooaukkse(eqrciduqyx) = pctryjwzjy wzzsdpnebh (jslgernugb )
-
03 Dec 2014
Placebo
kyooaukkse(eqrciduqyx) = yvifcyjvmr wzzsdpnebh (jslgernugb )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free